Bryant David Lim Idera Pharmaceuticals, Inc. (IDRA) insider trading activity

IDRA Quotes by TradingView

Bryant David Lim is SVP AND GENERAL COUNSEL of IDERA PHARMACEUTICALS, INC.. Currently has a direct ownership of 309,695 shares of IDRA, which is worth approximately $932,181. The most recent transaction as insider was on Jan 06, 2023, when has been sold 119,957 shares (Common Stock) at a price of $0.71 per share, resulting in proceeds of $85,169. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 310K
0% 3M change
0% 12M change
Total Value Held $932,181

Bryant David Lim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 06 2023
SELL
Payment of exercise price or tax liability
$85,169 $0.71 p/Share
119,957 Reduced 27.92%
309,695 Common Stock
Jan 06 2023
BUY
Grant, award, or other acquisition
-
399,218 Added 48.16%
429,652 Common Stock
Mar 25 2021
SELL
Open market or private sale
$10,377 $1.36 p/Share
7,630 Reduced 20.05%
30,434 Common Stock
Jan 12 2021
SELL
Open market or private sale
$7,203 $4.21 p/Share
1,711 Reduced 4.3%
38,064 Common Stock
Jan 05 2021
SELL
Open market or private sale
$5,728 $3.91 p/Share
1,465 Reduced 3.55%
39,775 Common Stock

Also insider at

PRLD
Prelude Therapeutics Inc Healthcare
CLO, Interim CFO, Corp Sec.
BDL

Bryant David Lim

SVP AND GENERAL COUNSEL
Exton, PA

Track Institutional and Insider Activities on IDRA

Follow IDERA PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDRA shares.

Notify only if

Insider Trading

Get notified when an Idera Pharmaceuticals, Inc. insider buys or sells IDRA shares.

Notify only if

News

Receive news related to IDERA PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IDRA